No Picture
Healthcare

Nova Mentis (OTC: NMLSF) Receives Health Canada Approval for First-Of-Its-Kind Psilocybin Clinical Trial

The human study will evaluate the Company’s proprietary psilocybin drug (NM-1001) in the treatment of Fragile X Syndrome Vancouver, British Columbia–(Newsfile Corp. – December 22, 2022) – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) […]

No Picture
Healthcare

Nova Mentis’ (OTC: NMLSF) Psilocybin Preclinical Study Published in International Science Journal

Microdose Treatment Modulates Cognition Vancouver, British Columbia— December 8, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and […]

Healthcare

Nova (OTC: NMLSF) Submits Phase II A Psilocybin Clinical Trial Application to Health Canada

Microdose Psilocybin Safety and Efficacy Clinical Study in Fragile X Syndrome Vancouver, British Columbia– November 30, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and […]

CEO Interview

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) Leading in PSYCHEDELICS Pharma 🚀

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) CMO Marvin Hausman, M.D.: “Nova’s Psilocybin-based Therapeutics Showing Vast Potential for Autism and Other Neuroinflammatory Disorders” 9/7/22 NEXT SUPER STOCK: Nova Mentis Life Sciences […]

Healthcare

Nova Mentis (OTC: NMLSF) Enters into Research Contract with KGK Science for Phase II A Clinical Trial

Vancouver, British Columbia-November 17, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (OTCQB: NMLSF) (FSE: HN3Q) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders […]

Healthcare

AI/ML Innovations’ (OTC: AIMLF) Tech2Heal Announces Second Pilot Study of its Proprietary Healthcare Management Platform – Alakin

– Alakin to be utilized in a Parkinson study set to commence in Paris, France – TORONTO, ON / August 2, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine […]

Healthcare

Nova Mentis (OTC: NMLSF) to Present Promising Psilocybin Microdose Data at 18th NFXF International Fragile X Conference

Vancouver, British Columbia- – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders, is pleased […]

No Picture
Healthcare

Kezar Life Sciences (NASDAQ: KZR) Announces Positive Topline Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib for the Treatment of Patients with Lupus Nephritis

11 of 17 patients (64.7%) achieved an overall renal response of 50% or greater reduction in urine protein to creatinine ratio (UPCR) at 6 months 6 of 17 patients (35.2%) achieved a complete renal response, including a […]

Healthcare

Nova Mentis (OTC: NMLSF) to Present at the H.C. Wainwright Mental Health Conference

Vancouver, British Columbia–June 22, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders […]

Healthcare

AI/ML Innovations’ (OTC: AIMLF) Tech2Heal Starts Medical Device ISO 13485 Certification Process

TORONTO, ON / June 22, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal […]

Healthcare

PharmaDrug (OTC: LMLLF) Announces Positive Findings for the Combination of Cepharanthine and Frontline Chemotherapy for IND-Enabling Esophageal Cancer Study

Results show that oral cepharanthine plus paclitaxel (combination therapy) significantly reduced tumor volume and increased tumor growth inhibition at day 28, the final day of dosing compared to paclitaxel alone (p=0.0049) Dose range finding demonstrates […]

Healthcare

Nova Mentis (OTC: NMLSF) and University of Central Florida to Develop Saliva Serotonin Assay

Vancouver, British Columbia–(Newsfile Corp. – June 9, 2022) – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics […]

No Picture
Healthcare

Stealth BioTherapeutics (NASDAQ: MITO) Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposium

SBT-272 improved neuronal health, superior to other approved and investigational agents Phase 1 study to evaluate safety and tolerability of SBT-272 in healthy volunteers is underway BOSTON, June 8, 2022 — Stealth BioTherapeutics Corp (NASDAQ: MITO), […]

No Picture
Healthcare

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax (NASDAQ: NVAX) COVID-19 Vaccine for People Aged 18 Years and Older

Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the […]